The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.EBI
University of Antwerp
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma.EBI
Northwestern University
An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells.EBI
Yantai University
The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance.EBI
Guangzhou University of Chinese Medicine
Targeting Atg4B for cancer therapy: Chemical mediators.EBI
Sichuan University
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.EBI
Gifu Pharmaceutical University
Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors.EBI
Roche Pharma Research and Early Development
Identification of benzo[cd]indol-2(1H)-ones as novel Atg4B inhibitors via a structure-based virtual screening and a novel AlphaScreen assay.EBI
Institute of Advanced Chemistry of Catalonia
Design of Small Molecule Autophagy Modulators: A Promising Druggable Strategy.EBI
China Pharmaceutical University
Immunomodulator compounds and methods of useBDB
Incyte
CDK inhibitorsBDB
Gi Therapeutics
Inhibitor of FLT3 kinase and use thereofBDB
Hefei Institutes of Physical Science, Chinese Academy of Sciences